FHTX vs DSGN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DSGN Captures Institutional Edge (2โ2 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Design Therapeutics, Inc. Common Stock (DSGN) driven by superior Momentum & Technical, Options & Structure while FHTX counters with relative strength in Valuation, Growth & Margin. Fundamentally, FHTX trades at N/M Forward P/E with 8.0% operating margin (+924.7% YoY revenue) versus DSGN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, FHTX sits in UNCLASSIFIED (34th %ile IV; Dealer Gamma Walls on Pro) against DSGN sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | FHTX | DSGN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $122.9M | $677.5M | Larger Scale | DSGN |
| Trailing P/E Ratio Valuation | 22.8x | N/M | Lower Multiple | FHTX |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +924.7% | +0.0% | Higher Growth | FHTX |
| Operating Margin (TTM) Profitability | 8.0% | 0.0% | Higher Margin | FHTX |
| Net Profit Margin Profitability | 8.4% | 0.0% | Higher Margin | FHTX |
| Return on Equity (ROE) Capital Efficiency | -470.4% | -36.9% | Higher ROE | DSGN |
| 52-Week Range Position Momentum | 0% ($2โ$8) | 30% ($7โ$17) | Stronger Trend | DSGN |
| Beta / 30D Volatility Risk Regime | 1.67ฮฒ ยท 79% Vol | 1.32ฮฒ ยท 61% Vol | Lower Realized Risk | DSGN |
| Unified Institutional Score Composite Signal | 35.3 / 100 (SELL) | 49.8 / 100 (HOLD) | Higher Composite | DSGN |